Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency

ObjectivePatients with adrenal insufficiency (AI) may be exposed to supraphysiological glucocorticoids levels during standard treatment with cortisone acetate (CA) or immediate-release hydrocortisone (IR-HC). Recent studies, predominantly including patients in IR-HC treatment, suggested that modifie...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sofia Frigerio, Giulia Carosi, Emanuele Ferrante, Elisa Sala, Elisa Polledri, Silvia Fustinoni, Bruno Ambrosi, Iacopo Chiodini, Giovanna Mantovani, Valentina Morelli, Maura Arosio
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2023-01-01
Ráidu:	Frontiers in Endocrinology
Fáttát:	adrenal insufficiency salivary cortisol Addison disease hydrocortisone modified-release hydrocortisone (MRH)
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1093838/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!